Freenome’s updated SimpleScreen CRC blood test met all primary and secondary endpoints in clinical validation, with improved sensitivity for precancerous lesions and colorectal cancer.
The Shield test is now available to eligible members aged 45 and older, expanding access to screening options for colorectal cancer.
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
Laboratories must now pay fees online and access certificates electronically as the program ends paper mailings.
The settlement resolves claims that Advanced Pathology Solutions provided illegal incentives to gastroenterology practices and performed unnecessary medical testing.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
CNSide Diagnostics has secured a national agreement with Elevance Health, expanding access to its CSF Tumor Cell Enumeration assay to 45.4 million more people in the US, Plus Therapeutics announced.
Position your laboratory for the future of hemostasis testing This sponsored white paper explores how advances in automation, workflow optimization, and intelligent coagulation analysis are helping laboratories improve...